中策集團(00235.HK)擬收購一間香港保險業務公司股權
格隆匯 11 月 4日丨中策集團(00235.HK)公告,公司現正評估一項潛在交易,包括但不限於收購一間於香港從事保險業務的公司的股權。如董事會決定進行潛在交易乃符合公司利益,其將會促使集團一成員公司就潛在交易初步投標程序提交一份無約束力的收購意向。由於在初步投標程序提交標書將由潛在賣家進行考慮及評核,因此無法確定潛在交易將按公司提出條款進行或全面進行。
公司將於有需要時就此另行刊發公佈。
集團主要從事投資證券、商品及電子組件貿易、放債及證券經紀業務。潛在交易為集團提供機會使其現有業務多元化並擴大其收入基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.